Introduction {#Sec1}
============

The retinal pigment epithelium (RPE) lies between the outer segments of the photoreceptors and the choroidal blood supply (Fig. [1](#Fig1){ref-type="fig"}). The RPE combines the functions of epithelial and glial cells, providing a barrier while also supporting the neural photoreceptors and modulating their function. Tight communication between photoreceptors and the RPE is critical to coordinate the multiple levels of interaction, and the purinergic contribution to this communication is becoming apparent. The relevance of this purinergic input is emphasized by the many functional effects of P1 and P2 receptor stimulation and by the multiple mechanisms in place to regulate subretinal levels of purine agonists. As the dynamics of ATP release and extracellular conversion into adenosine will modify agonist availability, the modulation of these processes can exert a temporal control on purinergic signaling. The following review will outline the main interactions between the RPE and photoreceptors, describe the effects of stimulating purinergic receptors on both sides of subretinal space, and summarize how levels of ATP, ADP, and adenosine are manipulated in this microenvironment. Fig. 1Schematic illustration of the key components of purinergic signaling in the subretinal microenvironment. Stimulation of P2 receptors on the RPE can enhance transepithelial fluid absorption while P1 receptors can modulate phagocytosis. ATP released through CFTR and other Cl^−^ channels can stimulate P2 receptors or be converted to ADP, AMP, and adenosine (*Ado*) by a series of ectonucleotidases present on the apical membrane of the RPE. By controlling the balance of extracellular purines available to stimulate these receptors these mechanisms can control levels of endogenous purines available to activate the receptors. While theoretically possible, it remains to be determined whether these subretinal purines can actually stimulate photoreceptors

Purines and subretinal space {#Sec2}
----------------------------

### RPE-photoreceptor interactions across the subretinal space {#Sec3}

The outer segments of the rods and cones are responsible for the initial stages of vision, converting photon energy into a series of enzymatic reactions that close the light-sensitive channels on the photoreceptor plasma membrane, hyperpolarize the cells, and reduce the release of glutamate from the synaptic terminals \[[@CR1], [@CR2]\]. Efficient photoreceptor function depends upon both short-term and long-term support from the RPE. The critical nature of these interactions is evident from the rapid degeneration of photoreceptors in the absence of a healthy RPE layer and by the RPE localization of defective gene product in some forms of hereditary photoreceptor degeneration \[[@CR3]\].

The apical membrane of the RPE is separated from the plasma membrane of the outer segments by an extracellular space of only 10--20 nm \[[@CR4]\]. Although small, this subretinal space contains a highly structured matrix which ensheathes the outer segments and extends to the RPE \[[@CR5], [@CR6]\]. The presence of enzymes within this interphotoreceptor matrix emphasizes that this extracellular space itself is functionally active \[[@CR7], [@CR8]\]. This intimate anatomical relationship between photoreceptors and the RPE reflects multiple functional interactions. For example, the RPE accepts, recycles, and exports central components of the phototransduction process \[[@CR9]\]. The outer segments are continuously resynthesized, and the phagocytosis, degradation, and processing of shed outer segment tips by the RPE cells is central to this renewal \[[@CR10]\]. The ion channels and transporters on the apical membrane of the RPE help regulate the ionic composition of the subretinal space \[[@CR11]\]. As extracellular levels of ions can modify the ionic driving forces across the photoreceptor plasma membrane, these RPE transporters can influence the state of neural activity. The transport of fluid and ions from the apical membrane to basolateral membrane of the RPE is also one of the main forces keeping the retina attached \[[@CR12]\].

The control of photoreceptor activity by light gives a rapid temporal dependence to some interactions between the photoreceptors and the RPE. The volume of subretinal space increases in response to light \[[@CR13]\], linking small changes in the ionic composition of the subretinal space with activity of the RPE transport mechanisms which maintain this volume \[[@CR14], [@CR15]\]. Other processes are controlled on a diurnal cycle. The shed tips of the outer segments are phagocytosed by the RPE soon after the onset of light \[[@CR16], [@CR17]\]. These processes can both be modulated by purine levels in subretinal space, indicating purinergic regulation is important over multiple time scales.

### Purinergic receptors on photoreceptors {#Sec4}

A~2~ adenosine receptors were localized to both the inner and outer segments of photoreceptor outer segments over a decade ago by Blazynski and colleagues \[[@CR18]\], with more recent reports emphasizing their functional role. A~2~ agonists inhibit the L-type Ca^2+^ channel on rod outer segments \[[@CR19]\] and can inhibit the synaptic release of glutamate from rods, suggesting changes in adenosine levels in subretinal space could modulate light sensitivity \[[@CR20]\]. The A~2~ agonist DPMA and the adenosine deaminase inhibitor EHNA reduce mRNA for opsin in rods, suggesting that endogenous levels of adenosine can downregulate opsin message at night \[[@CR21]\]. EHNA and the A~2A~ receptor agonist CGS21680 also increase the survival of chick embryonic photoreceptors in culture \[[@CR22]\], indicating a long-term neuroprotective role for adenosine.

P2 receptors are also present in the photoreceptors. mRNA for the P2X~2~ receptor is expressed in the photoreceptor cell bodies, with immunohistochemical localization of the protein to outer segments \[[@CR23]\]. In situ hybridization indicates the photoreceptor layer has the highest level of P2Y~2~ receptor of any region in the rabbit retina, although staining was not pronounced in monkey \[[@CR24]\]. P2X~7~ receptors have recently been localized to photoreceptor synaptic terminals, with evidence for ecto-ATPase activity in the synapse, and functional evidence suggesting ATP augments transmission of the light response by rods \[[@CR25]\]. It was suggested that ATP might be co-released from photoreceptors with glutamate, although this remains to be tested directly.

### Purinergic receptors on the RPE {#Sec5}

Stimulation of P1 receptors can have a considerable impact on RPE cells. A~2~ receptors have been recognized on cultured and fresh RPE cells for some time \[[@CR26], [@CR27]\], with in situ hybridization confirming the presence of A~2A~ receptors in rat RPE \[[@CR28]\]. Stimulation of A~2~ receptors reduces the rate of rod outer segment phagocytosis by RPE cells \[[@CR29]\], while application of adenosine to the apical membrane of chick RPE cells increases the basolateral Cl^-^ conductance, the transepithelial potential, and the c-wave, and decreases the hyperpolarization of the basal membrane in response to light \[[@CR30]\]. Although adenosine alone does not increase intracellular Ca^2+^ levels \[[@CR31]\], adenosine acts synergistically with ATP to elevate Ca^2+^ levels in human RPE cells by stimulating both A~1~ and A~2A~ receptors \[[@CR32], [@CR33]\]. Stimulation of A~1~ receptors with high doses of NECA increases the active transport of fluorescein across the RPE, while activation of A~2A~ receptors decreases this transport, and by extension, transport of the ions that underlie fluid movement \[[@CR34]\]. Stimulation of A~1~ and A~2A~ receptors produces analogous increases and decreases, respectively, in the absorption of subretinal fluid blebs. This is consistent with the negative coupling of the A~1~ receptor and the positive coupling of the A~2~ receptors to adenylate cyclase, as increasing cAMP inhibits the transport of fluid across the RPE towards the choroid \[[@CR35]--[@CR37]\]. The agonist 2-Cl adenosine reverses the deficit in phosphoinositide metabolism found in diabetic RPE cells \[[@CR38]\], suggesting effects on metabolism in addition to transport and phagocytosis.

Multiple P2 receptors have been localized to the RPE. The P2Y~2~ receptor was initially characterized in cultured human RPE \[[@CR31]\], with subsequent reports localizing transcript for P2Y~1~, P2Y~2~, P2Y~4~, and P2Y~6~ in the rat RPE/choroid \[[@CR39]\] and for P2Y~1~ and P2Y~12~ receptors in ARPE-19 cells \[[@CR40]\], and functionally identifying a P2X receptor in rat RPE cells \[[@CR41]\]. ATP, ADP, and UTP induce numerous effects on RPE physiology \[[@CR32], [@CR33], [@CR42], [@CR43]\]. While these effects likely involve multiple different receptor types, the contributions of the P2Y~2~ receptor have been explored in most detail to date. The P2Y~2~ receptor has been specifically localized to the apical membrane of fresh bovine RPE cells, and addition of ATP to this membrane transiently elevates Ca^2+^, activates a basolateral Cl^-^ conductance, inhibits an apical K^+^ conductance, and increases the apical to basolateral flow of fluid \[[@CR43]\]. This increased absorption of fluid from the subretinal space suggests P2Y~2~ receptor stimulation could reduce the excess fluid that accumulates in retinal edemas, and several reports have supported this theory. ATP, UTP, and the P2Y~2~ receptor agonist INS37217 decrease the size of subretinal fluid blebs when injected into subretinal space of rats \[[@CR44]\]. In both normal and rds +/- mice with experimentally induced detachment, INS31217 improves the ERG recovery and decreased cell death \[[@CR45]\]. INS37217 also reduces subretinal blebs in rabbits \[[@CR46]\]. Injection of another P2Y~2~ agonist, INS542, increases the active transport of fluorescein across the RPE, consistent with this upregulation of ion and fluid transport across the tissue \[[@CR47]\]. Together these experiments emphasize the clinical potential of treating retinal edema with P2Y~2~ agonists.

Regulation of purine levels in subretinal space {#Sec6}
-----------------------------------------------

While synthesized purinergic agonists may prove useful in treating some ocular disorders, the endogenous activation of P1 and P2 receptors in the subretinal microenvironment will ultimately be determined by availability of agonists. These levels are largely controlled by the release of ATP into the subretinal space, its conversion into other purines including adenosine, and the manipulation of adenosine by enzymes or transporters. Recent work has increased our understanding of both the stimuli that initiate changes in subretinal purine levels and the mechanisms that mediate these changes.

### Release of ATP by the RPE {#Sec7}

At least some of the ATP capable of stimulating the purinergic receptors on RPE cells is released from the RPE itself. The resulting autocrine stimulation ensures local delivery, and control, of purines to initiate the physiologic changes in the RPE. The release of ATP by RPE cells is triggered by multiple stimuli including osmotic stress, bFGF, UTP, NMDA, glutamate, and ATP \[[@CR39], [@CR40], [@CR48]--[@CR51]\]. The ATP release following activation of NMDA receptors by glutamate may have the most interesting implications for communication across subretinal space, given that glutamate confers the light signal from photoreceptors to the rest of the visual system. Glutamate and the specific receptor agonist NMDA triggers ATP release from ARPE-19 cells, with the release inhibited by NMDA antagonist MK-801, and by DCKA, which inhibits the glycine B binding site on NMDA receptors \[[@CR51], [@CR52]\]. Although NMDA raises intracellular Ca^2+^ levels, this increase is prevented by eliminating ATP with apyrase, indicating autostimulation through released ATP is responsible for this Ca^2+^ signal. NMDA also triggers a release of ATP when applied to the intact bovine RPE eyecup \[[@CR51]\]. The NMDA receptors and the ATP release sites have been functionally identified to the apical membrane of the bovine RPE, suggesting the neurotransmitter interactions could amplify the signal from any glutamate reaching subretinal space.

The ability of both UTP and ATP to stimulate release of ATP from the RPE supports the theory that the system acts to amplify signals. When applied at greater than 1 μM, ATP triggers a secondary release of ATP peaking 10 min after the initial stimuli \[[@CR40]\]. UTP also initiates a release in extracellular ATP with a similar delay \[[@CR48]\]. The rise in ATP triggered by UTP is inhibited by the Cl^-^ channel blocker NPPB, and UDP is much less effective at triggering release than UTP; both observations suggest the P2Y~2~ receptor contributes to the increase in ATP more than diphosphokinase, although influence from the enzyme cannot be ruled out \[[@CR53]\].

Recent evidence suggests that ischemia may lead to the release of ATP from RPE cells. Chemical ischemia triggers a substantial ATP release from cardiac myocytes \[[@CR54]\], while changes in oxygen levels trigger ATP release in central chemoreceptors \[[@CR55]\]. We found that exposure to sodium cyanide led to a rapid release of ATP from ARPE-19 cells (Fig. [2](#Fig2){ref-type="fig"}). As hypoxic and/or ischemic challenge may lead to changes in the expression of growth factors in RPE cells during certain ocular disorders such as macular degeneration \[[@CR56]\], and as purines can induce expression of VEGF in other cells \[[@CR57]\], this ATP release may contribute to growth factor signaling by the diseased RPE. Fig. 2Chemical ischemia triggers ATP release from ARPE-19 cells. ATP release was measured in the bath directly from cells plated in 96-well plates to which the luciferin- luciferase reaction mixture was added \[[@CR51]\]. *Left* Levels of ATP in the bath after addition of 5 mM NaCN to the cells. Measurement began 1 min after addition of NaCN or control solution to wells. *Right* Levels of ATP measured at the peak, 3 min after addition of NaCN (*n* = 12). Levels were normalized to concurrent levels in control (*n* = 14). Symbols and bars represent mean ± SE, \**p* \< 0.001

The particular conduit for ATP release varies with the stimuli. The release in response to hypotonic challenge is largely dependent upon CFTR, as it was prevented by the specific CFTR inhibitor CFTR~172~ in addition to the more general blocker glybenclamide \[[@CR50]\]. While the precise mechanisms by which CFTR contributes to this release are not yet known, a role for CFTR in ATP release into subretinal space is consistent with the reduction of certain ERG components in *cftr -/- mice* \[[@CR58]\] and with the ability of apical ATP to activate conductances associated with these ERG components \[[@CR43]\]. The release of ATP is also largely blocked by the vesicular transport inhibitor brefeldin A, suggesting the two processes occurred in series whereby ATP efflux follows the insertion of vesicles containing CFTR into the plasma membrane. Although the Ca^2+^ chelator BAPTA blocks this ATP release \[[@CR50]\], raising Ca^2+^ alone with ionophore ionomycin does not itself initiate release \[[@CR48]\]. This necessary but not sufficient contribution of Ca^2+^ also supports a role for vesicular insertion.

In contrast to the release following hypotonic challenge, the ATP release in response to NMDA does not involve CFTR \[[@CR51]\]. Release is blocked by NPPB, however, suggesting another type of anion channel could serve as a conduit for ATP release. The presence of parallel mechanisms coexisting on the same cell for ATP release triggered by either agonists or by cell swelling has also been reported in astrocytes \[[@CR59]\] and may reflect the multiple roles of purinergic signaling within a given tissue. As both stimuli lead to release across the apical membrane into subretinal space, both are expected to influence signaling in the microenvironment.

### Interconversion of purines in subretinal space {#Sec8}

The interconversion of nucleotides and nucleosides each capable of stimulating distinct receptors makes the purinergic signaling system of particular interest in a confined region such as the subretinal space. The main enzymes responsible for dephosphorylating extracellular ATP on the RPE cells have been analyzed and a basic understanding of their regulation has begun. This section first describes the enzymes that act on ATP and ADP, followed by enzymes which convert AMP into adenosine.

The dephosphorylation of extracellular ATP by RPE cells involves enzymes from multiple families \[[@CR40]\], as found in airway epithelial cells \[[@CR60]\]. Degradation of ATP by the apical membrane of the fresh bovine eyecup and by ARPE-19 cells is inhibited by ARL67156 or βγmATP. Message for eNPP1, eNPP2, and eNPP3 is present in ARPE-19 cells, consistent with the preference of βγmATP for members of the eNPP family \[[@CR61]\]. The cells also express NTPDase2, and NTPDase3, although the intermittent presence of NTPDase1 likely reflects a regulated process \[[@CR40]\]. Ecto-alkaline phosphatase has no effect on ATP degradation in RPE cells, in contrast to its considerable contribution in airway epithelium \[[@CR62]\]. The putative contribution from diphosphokinases to interconversion of subretinal purines is presently unknown.

Extracellular AMP is rapidly dephosphorylated into adenosine in subretinal space. The production of adenosine from ATP at the apical membrane of the bovine RPE eyecup is inhibited by the ecto-5′-nucleotidase inhibitor αβmADP, confirming a role for this enzyme \[[@CR63]\]. The enzyme is localized to rat RPE and ARPE-19 cells immunohistochemically. Degradation of 5′AMP is highest near the subretinal space of rat retina \[[@CR63]\], although localization in mouse indicated larger amounts of ecto-5′-nucleotidase at the tips of adjacent Müller cells \[[@CR64]\]. Levamisole does not inhibit the dephosphorylation of 5′AMP by the RPE, consistent with the absence of substantial ecto-alkaline phosphatase in subretinal space.

The presence of light may alter the levels of adenosine in subretinal space. Epinephrine is released at the onset of light \[[@CR65]\] and stimulation of the RPE with epinephrine can decrease activity of ecto-5′-nucleotidase \[[@CR63]\]. While norepinephrine and phenylephrine lead to similar decreases in enzyme activity, prazosin and corynanthine block the effects of norepinephrine, implicating the α1 epinephrine receptor in the inhibition of ecto-5′-nucleotidase \[[@CR63]\]. The kinetics of inhibition are consistent with cleavage of the nucleotidase from its GPI anchor. The phagocytosis of rod outer segments is maximal shortly after light onset \[[@CR16]\], and this phagocytosis is inhibited by adenosine \[[@CR29]\]. The ability of epinephrine released by the illuminated retina to reduce ecto-5′-nucleotidase activity and consequently adenosine levels may relieve this inhibition and enhance the rate of phagocytosis at light onset.

Physiologic effects of subretinal purines on the RPE and photoreceptors {#Sec9}
-----------------------------------------------------------------------

The number of purinergic receptors on both photoreceptor and RPE membranes suggests purines make multiple contributions to the physiology of the outer retina. Our increased understanding of how agonist levels in subretinal space are controlled has begun to indicate how and when this contribution may occur. Future research will involve applying these findings from isolated systems to intact RPE-photoreceptor models, and pursuing the role of defective purinergic regulation in ocular disease. While it is unlikely that ATP released across the apical membrane of the RPE can diffuse to these P2 receptors in the outer plexiform layer given the ecto-ATPase activity in the synaptic clef \[[@CR25]\], stimulation of receptors elsewhere on the photoreceptor membrane is possible. It would be interesting to determine whether ATP released from the RPE and converted to adenosine by ecto-nucleotidases can actually modulate the response to light by stimulating the A~2A~ receptors on photoreceptor outer segments. The impact of purinergic signaling on chronic ocular diseases is also of interest, such as the role of ischemia-driven ATP release in VEGF production. While the small size of subretinal space can complicate pharmacologic manipulation within the intact RPE-photoreceptor complex, molecular approaches may provide new insight into how endogenous purines in subretinal space affect the physiology, and pathophysiology, of both RPE and photoreceptors.
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ADP

:   adenosine diphosphate

AMP

:   adenosine monophosphate

ATP

:   adenosine triphosphate

ARL67156

:   6-*N*,*N*-diethyl-[D]{.smallcaps}-β,γ-dibromomethylene ATP

BAPTA

:   (1,2-bis(o-aminophenoxy)ethane-*N*,*N*,*N*′,*N*′-tetraacetic acid)

bFGF

:   basic fibroblast growth factor

CFTR

:   cystic fibrosis transmembrane conductance regulator

CGS21680

:   (2-\[p-(2-carboxyethyl)phenylethylamino\]-5′-*N*-ethyl-carboxamidoadenosine

DCKA

:   5, 7-dichlorokynurenic acid

DMPA

:   *N*(6)-\[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl\]adenosine

EHNA

:   erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride

ENPP

:   ectonucleotide pyrophosphatase/phosphodiesterase

ERG

:   electroretinogram

GPI

:   glycosylphosphatidylinositol

MK-801

:   (+)-5-methyl-10,11-dihydro-5H-dibenzo\[a,d\]cyclohepten-5,10-imine maleate

NECA

:   adenosine-5′-*N*-ethylcarboxamide

NMDA

:   *N*-methyl-[D]{.smallcaps}-aspartic acid

NPPB

:   5-nitro-2-(3-phenylpropylamino)-benzoate

NTPDase

:   ectonucleoside triphosphate diphosphohydrolase

UDP

:   uridine diphosphate

UTP

:   uridine triphosphate

VEGF

:   vascular endothelial growth factor
